米非司酮联合手术治疗剖宫产术后腹壁切口子宫内膜异位症的疗效分析

Clinical analysis of mifepristone combination with surgical treatment of abdominal wall after cesarean section incision endometriosis

目的对剖宫产术后腹壁切口子宫内膜异位症进行临床分析研究。方法选取来本院接受剖宫产术后腹壁切口子宫内膜异位症治疗的患者36例。所有患者在常规手术治疗后均使用药物进行辅助治疗,其中19例患者术后使用孕三烯酮进行治疗作为对照组,17例患者手术后使用米非司酮进行治疗作为观察组。手术后随访8～12个月。以两组患者的治疗效果及复发情况作为临床观察指标进行比较分析。结果观察组临床治疗效果明显优于对照组(P<0.05);观察组复发情况也明显优于对照组(P<0.05)。结论在传统手术治疗的基础上,采用米非司酮进行辅助治疗可有效地提高剖宫产术后腹壁切口子宫内膜异位症的临床治疗效果。

Objective To research endometriosis in the abdominal wall after cesarean section incision. Methods Thir- ty-six cases of patients who came to our hospital for cesarean section abdominal incision endometriosis treatment were selected. All of the patients were given drugs for adjuvant treatment after traditional surgery. 19 patients who used the gestrinone after the operation as the control group, and 17 patients who used the mifepristone as the observation group. Followed up for 8-12 months after surgery. The treatment effect and recurrence of two groups were compared. Results The total effective rate of the observation group was significantly higher than the control group （P 〈 0.05）; The recur- rence, complications of the observation group was significantly better than the control group （P 〈 0.05）. Conclusion Using the mifepristone based on the traditional treatment can effectively increase the therapeutic effect of cesarean section abdominal incision endometriosis.